Cord tissue is the actual umbilical cord and the cells contained within. It is an abundent source of Mesenchymal Stem Cells (MSCs). Learn more about cord tissue
Cord tissue stem cells, or Mesenchymal Stem Cells (MSCs), are the “building blocks” of the body’s skeletal and connective tissues. They have also shown the ability to differentiate into coronary tissue, hepatic tissue and more.
Cord blood and cord tissue yield two vastly different types of stem cells that can potentially be used to treat different diseases and conditions within the body.
Cord blood stem cells are called Hematopoietic Stem Cells (HSCs). The primary focus in research with HSCs has been on blood and immune system disorders.
The stem cells derived from cord tissue are called Mesenchymal stem cells (MSCs). Researchers have focused their efforts on connective tissue disorders and regenerative medicine with this kind of stem cell.
Saving both cord blood and cord tissue will provide your family with the widest potential scope of treatment options. Learn more.
Cord tissue stem cells (MSCs) represent the most advanced, cutting-edge discoveries in regenerative medicine today.
With over 300 MSC clinical trials in progress, scientists predict an explosion of new therapies will emerge, including routine treatments for diabetes, multiple sclerosis, stroke, heart failure, cirrhosis, bone fractures, autoimmune diseases and many more.
Yes. MSCs are considered to be immunoprivileged. This means that MSCs can be used to treat an immediate family member with little risk of transplant rejection or GVHD.
No. Currently, there are no public cord blood or tissue banks that will collect, process and store MSCs for future transplantation.
Yes. Cord tissue stem cells can be expanded, which multiplies the number of viable stem cells to doses that are suitable for an adult transplant.